Branko Zakotnik

Crizotinib achieves long-lasting disease control in advanced papillary renal-cell carcinoma type 1 patients with MET mutations or amplification. EORTC 90101 CREATE trial

Patrick Schöffski, Agnieszka Woźniak, Bernard Escudier et al. · European Journal of Cancer · 2017 · 115 citations

Medicine, Oncology, Pharmacology +10

Activity and safety of crizotinib in patients with alveolar soft part sarcoma with rearrangement of TFE3: European Organization for Research and Treatment of Cancer (EORTC) phase II trial 90101 ‘CREATE’

Patrick Schöffski, Agnieszka Woźniak, Bernd Kasper et al. · Annals of Oncology · 2017 · 89 citations · Full text

Medicine, Oncology, Pharmacology +11

Severe forms of tick-borne encephalitis in children.

Milan Čižman, Rasta Rakar, Branko Zakotnik et al. · PubMed · 1999 · 72 citations

Medicine, Neurology, Pediatrics +14

Detection of Hepatitis C Virus RNA From Gingival Crevicular Fluid and Its Relation to Virus Presence in Saliva

Mojca Matičičr, Mario Poljak, Barbara Kramar et al. · Journal of Periodontology · 2001 · 62 citations

Dentistry, Periodontics, Periodontology +17

Postoperative concomitant irradiation and chemotherapy with mitomycin C and bleomycin for advanced head-and-neck carcinoma

Lojze Šmid, Marjan Budihna, Branko Zakotnik et al. · International Journal of Radiation Oncology*Biology*Physics · 2003 · 58 citations

Medicine, Oncology, Surgery +9